The impact of novel inflammation-preserving treatment towards lumbar disc herniation resorption in symptomatic patients: a prospective, multi-imaging and clinical outcomes study.
Hanne B AlbertArash J SayariJ Nicolas BarajasAlexander L HornungGarrett HaradaMichael T NolteAna V CheeDino SamartzisAlexander TkachevPublished in: European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society (2023)
This is the first study to note inflammation-preserving treatment, without conventional anti-inflammatory and steroid medications, as safe and effective for patients with an acute LDH. Rate of disc resorption (100%) was higher than comparative recent meta-analysis findings (66.7%) and no patient underwent surgery.
Keyphrases
- systematic review
- minimally invasive
- oxidative stress
- end stage renal disease
- anti inflammatory
- newly diagnosed
- ejection fraction
- chronic kidney disease
- randomized controlled trial
- high resolution
- peritoneal dialysis
- case report
- coronary artery disease
- coronary artery bypass
- intensive care unit
- percutaneous coronary intervention
- hepatitis b virus
- smoking cessation